Average Co-Inventor Count = 4.59
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Mannheim Italia, S.p.a. (8 from 25 patents)
2. Cephalon, Inc. (6 from 247 patents)
3. Roche Diagnostics Gmbh (5 from 480 patents)
4. Novuspharma S.p.a. (5 from 6 patents)
5. Hoffmann-la Roche Inc. (3 from 4,945 patents)
6. University of Vermont and State Agricultural College (2 from 204 patents)
7. F. Hoffmann-la Roche Ag (2 from 168 patents)
8. University of Vermont (2 from 43 patents)
9. Boehringer Biochemia Robin S.p.a. (2 from 22 patents)
10. Millennium Pharmaceuticals Limited (1 from 850 patents)
11. Virginia Commonwealth University (1 from 402 patents)
12. Cell Therapeutics, Inc. (1 from 103 patents)
13. Boehringer Mannheim Italia (1 from 2 patents)
14. Boehringer Mannhein Italia, S.p.a. (1 from 1 patent)
36 patents:
1. 9233115 - Proteasome inhibitors and methods of using the same
2. 8546608 - Proteasome inhibitors and methods of using the same
3. 8426625 - Bis-platinum complexes with antitumor activity
4. 8283367 - Proteasome inhibitors and methods of using the same
5. 8058262 - Proteasome inhibitors and methods of using the same
6. 7915236 - Proteasome inhibitors and methods of using the same
7. 7468383 - Proteasome inhibitors and methods of using the same
8. 7223745 - Proteasome inhibitors and methods of using the same
9. 6987122 - 2-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity
10. 6753342 - 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
11. 6716845 - Barbituric acid derivatives
12. 6596889 - Nitrates of bis-platinum complexes with polyamine ligands
13. 6576628 - 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same
14. 6498252 - Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
15. 6472396 - Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds